| 证券代码：603058 | 证券简称：永吉股份 | 公告编号：2023-070 | | --- | --- | --- | | 转债代码：113646 | 转债简称：永吉转债 | | 贵州永吉印务股份有限公司 第五届监事会第十九次会议决议公告 一、监事会会议召开情况 贵州永吉印务股份有限公司（以下简称"公司"）第五届监事会第十九次会 议于 2023 年 8 月 17 日以现场会议的方式召开。本次监事会会议通知于 2023 年 8 月 7 日以微信、电话等形式送达。会议由监事会主席弋才伟先生召集并主持， 会议应出席监事 3 名，实际出席监事 3 名。会议召集及召开方式符合《中华人 民共和国公司法》、《贵州永吉印务股份有限公司章程》等有关规定，所形成的 决议合法有效。 二、监事会会议审议情况 表决结果：同意 3 票，反对 0 票，弃权 0 票。 （二）审议通过《关于 2023 年半年度募集资金存放与实际使用情况专项报 告的议案》 相 关 内 容 请 查 阅 公 司 在 指 定 信 息 披 露 媒 体 上 海 证 券 交 易 所 网 站 （www.sse.com.cn）披露的公司《2023年半年度募集资金存放与 ...

独立董事对公司第五届董事会第二十一次会议 相关事项的独立意见 贵州永吉印务股份有限公司 薛军 段竞晖 王强 贵州永吉印务股份有限公司 2023年8月17日 根据《中华人民共和国公司法》(以下简称"《公司法》")《中华 人民共和国证券法》(以下简称"《证券法》")《上市公司治理准则》 《上海证券交易所股票上市规则》等有关规定和《贵州永吉印务股份有限 公司章程》的相关要求,作为贵州永吉印务股份有限公司 (以下简称"公 司")的独立董事,基于独立判断的立场,现对公司第五届董事会第二十 一次会议审议的相关事项发表如下独立意见: 一、关于2023年半年度募集资金存放与实际使用情况专项报告的意见 经审阅,我们认为:公司编制的《2023年半年度募集资金存放与实际 使用情况专项报告》内容真实、准确、完整,真实反映了公司2023年上半 年募集资金存放、使用、管理等方面的情况。公司募集资金的存放与使用 符合中国证监会、上海证券交易所关于上市公司募集资金存放与使用的相 关规定,不存在募集资金存放和使用违规的情形,不存在改变或变相改变 募集资金投向和损害股东尤其是中小股东利益的情况。 因此,我们同意公司《2023年半年度募集资金存放 ...

| 证券代码：603058 | 证券简称：永吉股份 | 公告编号：2023-069 | | --- | --- | --- | | 转债代码：113646 | 转债简称：永吉转债 | | 贵州永吉印务股份有限公司 第五届董事会第二十一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 贵州永吉印务股份有限公司（以下简称"公司"）于2023年8月7日以书面、 电话、微信等方式向公司全体董事发出董事会通知。公司第五届董事会第二十一 次会议于2023年8月17日以现场及网络视频会议的方式召开。会议应到董事7人， 实到董事7人。 会议由公司董事长召集并主持。本次会议的召开符合《中华人民共和国公司 法》等有关法律法规及《贵州永吉印务股份有限公司章程》的有关规定。 相 关 内 容 请 查 阅 公 司 在 指 定 信 息 披 露 媒 体 上 海 证 券 交 易 所 网 站 （www.sse.com.cn）披露的公司《2023年半年度报告及其摘要》。 表决结果：同意 7 票，反对 0 票，弃权 0 票。 （ ...

贵州永吉印务股份有限公司 2023 年半年度募集资金存放与实际使用情况 的专项报告 | 证券代码：603058 | 证券简称：永吉股份 | 公告编号：2023-072 | | --- | --- | --- | | 转债代码：113646 | 转债简称：永吉转债 | | 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要 求》、《上海证券交易所上市公司自律监管指引第 1 号——规范运作》等相关规 定，将贵州永吉印务股份有限公司（以下简称"公司"）2023 年半年度募集资 金存放与使用情况专项说明如下： 一、募集资金基本情况 （一）实际募集资金金额、资金到位情况 经中国证券监督管理委员会出具的《关于核准贵州永吉印务股份有限公司公 开发行可转换公司债券的批复》（证监许可[2021]2509 号），公司于 2022 年 4 月 20 日公开发行可转换公司债券 1,458,680 张，每张面值为人民币 100.00 元， 募集资金总额为人民币 145,868,000. ...

| 证券代码：603058 | 证券简称：永吉股份 | 公告编号：2023-060 | | --- | --- | --- | | 转债代码：113646 | 转债简称：永吉转债 | | 贵州永吉印务股份有限公司 关于召开 2022 年度业绩说明会的公告 本次投资者说明会以视频结合网络互动召开，公司将针对 2022 年度经营成 果及财务指标的具体情况与投资者进行互动交流和沟通，在信息披露允许的范围 内就投资者普遍关注的问题进行回答。 二、说明会召开的时间、地点 （网址：http://roadshow.sseinfo.com/） 会议召开时间：2023 年 06 月 13 日(星期二) 上午 10:00-11:30 会议召开地点：上海证券交易所上证路演中心 （一）会议召开时间：2023 年 06 月 13 日 上午 10:00-11:30 会议召开方式：上证路演中心视频直播和网络互动 投资者可于 2023 年 06 月 06 日(星期二) 至 06 月 12 日(星期一)16:00 前登 录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 dsh@yongjigf.com 进行提问。公司将在说明会上对投 ...

| 证券代码：603058 | 证券简称：永吉股份 公告编号：2023-053 | | --- | --- | | 转债代码：113646 | 转债简称：永吉转债 | 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 贵州永吉印务股份有限公司 关于参加贵州辖区上市公司投资者线上集体接 待日活动暨线上业绩说明会的公告 贵州永吉印务股份有限公司（以下简称"公司"）于 2023 年 3 月 31 日在上 海证券交易所网站（www.sse.com.cn）披露了《2022 年年度报告》。为加强与 投资者的互动交流和沟通，使投资者更加全面、深入地了解公司 2022 年度经营 成果、财务状况，公司将参加由贵州证监局、贵州证券业协会与深圳市全景网络 有限公司联合举办的贵州辖区上市公司投资者集体接待日暨 2022 年度业绩说明 会活动。本次年度业绩说明会将采用网络远程的方式举行，投资者可登陆"全景 路演"（http://rs.p5w.net）参与本次年度业绩说明会。 重要内容提示： ● 会议召开形式：网络文字互动 ● 会议召开形式：提问通道自本公 ...

Financial Performance - The company's operating revenue for Q1 2023 reached ¥173,862,414.52, representing a year-on-year increase of 47.25%[3] - Net profit attributable to shareholders was ¥30,906,162.14, with a significant increase in net profit excluding non-recurring gains and losses to ¥30,982,916.52, up 1,038.31%[3] - Operating profit for Q1 2023 was ¥35,911,110.01, recovering from a loss of ¥27,960,757.81 in Q1 2022[20] - Net profit for Q1 2023 was ¥30,202,186.00, compared to a net loss of ¥24,529,016.58 in Q1 2022, marking a turnaround[20] - The total comprehensive income for Q1 2023 was ¥26,494,899.22, compared to a loss of ¥18,981,156.40 in Q1 2022, indicating improved overall performance[20] - The company reported a basic earnings per share of ¥0.072 for Q1 2023, recovering from a loss of ¥0.058 per share in Q1 2022[20] Cash Flow - The net cash flow from operating activities was ¥7,193,699.34, indicating a positive cash flow situation[3] - Cash flow from operating activities generated a net amount of ¥7,193,699.34 in Q1 2023, a recovery from a negative cash flow of ¥51,726,427.74 in Q1 2022[23] - The net cash flow from investment activities was $114,792,963.62, a significant improvement compared to a negative cash flow of -$42,075,675.35 in the previous period[24] - Cash and cash equivalents at the end of the period totaled $376,176,015.93, up from $259,071,664.47 in the previous period[24] - The net cash flow from financing activities was -$1,739,551.30, compared to a positive cash flow of $333,008.95 in the previous period[24] - The company’s cash flow from financing activities included $14,797,404.00 for debt repayment, reflecting a strategic focus on managing liabilities[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,760,183,775.95, showing a slight increase of 0.01% compared to the end of the previous year[4] - The total current assets decreased to CNY 797,223,833.25 from CNY 892,522,583.51, indicating a decline of about 10.6%[16] - The company's long-term equity investments rose to CNY 60,319,464.55 from CNY 50,283,474.42, reflecting an increase of approximately 19.9%[16] - The total liabilities decreased to CNY 551,688,228.03 from CNY 578,034,230.44, showing a reduction of about 4.6%[17] - The company's accounts receivable decreased to CNY 123,698,335.82 from CNY 168,641,151.74, representing a decline of approximately 26.6%[15] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 14,238, with the largest shareholder holding 41.18% of the shares[7] - The company plans to implement a cash dividend of CNY 2.5 per 10 shares for the 2022 fiscal year, subject to shareholder approval[13] Research and Development - Research and development expenses surged by 77.14%, reflecting the company's increased investment in new products and technologies[6] - Research and development expenses increased to ¥9,202,666.51 in Q1 2023, up from ¥5,195,045.47 in Q1 2022, reflecting a focus on innovation[19] Future Plans - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[6] - The company is in the process of a non-public offering of A-shares, with relevant proposals approved by the board in early 2023[12] - The company completed the registration of the 2022 restricted stock incentive plan on February 28, 2023, following board and shareholder approvals[10] Other Information - The report was officially announced by the board of directors on April 28, 2023[26] - The company did not apply new accounting standards for the first quarter of 2023[25]

Dividend Distribution - The company plans to distribute a cash dividend of 2.5 yuan (pre-tax) for every 10 shares, totaling approximately 103,674,964.50 yuan for the year 2022[6]. - The cash dividend distribution date is set for September 30, 2022, with the record date being September 29, 2022[6]. - The company does not plan to issue new shares or convert capital reserves into share capital in the current profit distribution[6]. - The company’s cash dividends are contingent upon achieving positive distributable profits and receiving an unqualified audit opinion on financial reports[138]. - The company implements an active dividend distribution policy, prioritizing cash dividends, which should not be less than 20% of the distributable profit for the year[138]. Financial Performance - The company achieved a total revenue of RMB 653.34 million in 2022, representing a year-on-year increase of 49.86%[23]. - Net profit attributable to shareholders decreased by 72.54% to RMB 37.78 million, while the net profit after deducting non-recurring gains and losses increased by 253.55% to RMB 82.73 million[23]. - Operating cash flow increased by 173.09% to RMB 100.23 million, driven by significant growth in sales revenue[25]. - The company's weighted average return on equity decreased by 8.37 percentage points to 3.41%[25]. - Basic earnings per share fell to RMB 0.0911, a decrease of 72.39% compared to the previous year[24]. Revenue Breakdown - Sales revenue from cigarette labels increased by 54.35%, and sales from medical cannabis in Australia surged by 2084.95%[25]. - The revenue from the cigarette label business was 460.47 million yuan, up 54.35% year-on-year, while the wine label business revenue reached 109.08 million yuan, growing by 15.81%[32]. - In the medical cannabis sector, the company’s subsidiary TB achieved sales revenue of 8.2936 million AUD (approximately 38.70451 million yuan), a year-on-year increase of 2084.95%[51]. Assets and Liabilities - The total assets of the company at the end of 2022 were RMB 1.76 billion, an increase of 4.82% from the previous year[23]. - The company reported a net asset attributable to shareholders of RMB 1.05 billion, down 4.39% from the previous year[23]. - The company’s equity attributable to the parent company was 1.05 billion yuan, a decrease of 4.39% from the beginning of the reporting period[61]. Research and Development - The company invested 35,247,549.52 yuan in R&D, an increase of 13.56% year-on-year, and developed a total of 240 new product samples, with 70 products entering production[35]. - The company developed and sampled 50 new cigarette label products in 2022, with 7 products entering production[60]. - For wine label products, the company developed and sampled 174 products, with 50 products entering production[60]. Market Expansion - The company plans to continue expanding its product offerings and market presence, particularly in the medical cannabis sector[25]. - The company is actively pursuing opportunities in the industrial hemp market, which has shown significant growth potential, particularly in Australia[42]. - The company is exploring the development of industrial hemp applications, with a focus on plant-based protein and hemp core materials, aiming to expand into the consumer goods and health industries[37]. Corporate Governance - The company has established a comprehensive governance structure to protect the rights of all shareholders, especially minority shareholders[113]. - The board of directors consists of three members, all of whom are independent directors, ensuring compliance with legal requirements[114]. - The company has not faced any penalties from securities regulatory agencies in the past three years[125]. Environmental Responsibility - The company invested 930,000 RMB in environmental protection during the reporting period[150]. - The company effectively managed wastewater, with all production wastewater being recycled and treated, ensuring compliance with national standards[152]. - The company implemented measures to control emissions of VOCs and other pollutants, with all monitored emissions below regulatory limits[153]. Shareholder Structure - The largest shareholder, Guizhou Yongji Holdings Co., Ltd., holds 172,566,200 shares, representing 41.18% of the total shares, with 84,557,400 shares pledged[199]. - The total number of ordinary shareholders increased from 14,117 to 14,570 during the reporting period[197]. - The top ten shareholders include a mix of corporate and individual investors, with the largest individual shareholder, Deng Weijia, holding 22,000,000 shares, or 5.25%[199]. Risk Management - The company is facing risks from raw material price fluctuations, with direct materials accounting for approximately 70% of its operating costs[108]. - The company is closely monitoring exchange rate fluctuations, particularly between the RMB and AUD, to manage foreign exchange risk[111]. - The company is facing intensified competition in the tobacco industry, leading to potential price reductions and profit margin compression[110].

2022 年第三季度报告 证券代码：603058 证券简称：永吉股份 一、 主要财务数据 贵州永吉印务股份有限公司 2022 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期 比上年同 | | 年初至报告期 末比上年同期 | | --- | --- | --- | --- | --- | | | | | 年初至报告期末 | | | | | 期增减变 | | 增减变动幅度 | | | | 动幅度(%) | | (%) | | 营业收入 | 128,581,610.22 | 29.74 | 380,023,950.04 | 37.29 | | 归属于上市公司股东的 | -25,918,008.72 | -156.14 | -13,417,034.87 | -109.98 | | 净利润 | | | | | | 归属于上市公司股东的 | | | | | | 扣除非经常性损益的净 | 8,619,542.67 | ...

Financial Performance - The company achieved operating revenue of RMB 251.44 million, an increase of 41.50% compared to the same period last year[21]. - Net profit attributable to shareholders decreased by 85.83% to RMB 12.50 million, while the net profit excluding non-recurring gains and losses increased by 24.15% to RMB 23.27 million[21]. - The weighted average return on net assets decreased by 6.22 percentage points to 1.13%[20]. - Total assets increased by 6.50% to RMB 1.79 billion compared to the end of the previous year[21]. - The net cash flow from operating activities decreased by 41.29% to RMB 53.31 million[20]. - The company reported a loss of RMB 14.40 million from investments in private equity funds, a decrease of 118.61% compared to the previous year's similar business income[21][23]. - The company’s net assets attributable to shareholders increased by 2.39% to RMB 1.13 billion compared to the end of the previous year[20]. - The company reported a net profit of 12.50 million yuan, a decline of 85.83% year-on-year, primarily due to losses in securities investments[46]. Revenue Breakdown - The sales revenue from tobacco label products increased by 49.36% to RMB 170.42 million, while the sales revenue from wine label products grew by 18.01% to RMB 49.53 million[21]. - The overseas subsidiary TB achieved sales revenue of RMB 12.15 million, a significant increase of 135.42% year-on-year[21]. - Revenue from the cigarette label business was 170.42 million yuan, up 49.36% year-on-year, while the wine label business generated 49.53 million yuan, an increase of 18.01%[46]. - The company achieved a sales revenue of 49.53 million RMB for wine labels in the first half of 2022, representing an 18.01% increase compared to the same period last year[32]. Product Development and Innovation - The company designed and developed 75 wine label products during the reporting period, with 7 products entering mass production[32]. - The company plans to launch 2-5 new products in the medical cannabis sector in the next six months, including high THC flower products[35]. - The company invested 12.13 million yuan in R&D during the reporting period, reflecting a year-on-year increase of 21.08%[47]. - The company developed 17 new cigarette label products, with 7 entering mass production, and 75 new wine label products, with 7 also in production[43]. Environmental Compliance - The company has implemented strict pollution control measures, ensuring that wastewater discharge complies with national standards, with no exceedance reported[80]. - The company has established effective waste gas treatment systems, with emissions from ink and oil smoke meeting regulatory requirements[82]. - The company has received the Pollution Discharge Permit from the Guizhou Provincial Environmental Protection Bureau, confirming compliance with environmental regulations[85]. - The company has set up an emergency response plan for environmental pollution incidents, which has been filed with local environmental authorities[86]. Financial Structure and Capital Management - The company issued 1,458,680 convertible bonds in April 2022, raising a total of 145.868 million yuan[100]. - The company’s controlling shareholder has committed to measures to mitigate the dilution of immediate returns due to the issuance of convertible bonds[101]. - The company’s board and senior management have pledged to uphold their duties and ensure compliance with regulations regarding the execution of return compensation measures[103]. - As of June 30, 2022, the company had a debt-to-asset ratio of 29.58%, indicating a stable financial structure[125]. Shareholder Information - The total number of ordinary shareholders as of the end of the reporting period was 18,534[111]. - The largest shareholder, Guizhou Yongji Holding Co., Ltd., held 172,566,200 shares, accounting for 41.18% of the total shares[114]. - The company completed a share buyback, with the repurchased shares totaling 4,379,000, representing 1.0449% of the total share capital[114]. Risk Management - The company emphasizes the importance of risk awareness regarding future plans and development strategies[5]. - The report includes a section on major risks that investors should review[6]. - The company is closely monitoring exchange rate fluctuations, particularly between the CNY and AUD, to manage foreign exchange risks effectively[71]. Corporate Governance - The company guarantees the authenticity, accuracy, and completeness of the semi-annual report, with all directors present at the board meeting[7]. - There are no non-operating fund occupations by controlling shareholders or related parties[6]. - The company has no violations in decision-making procedures for external guarantees[6]. Accounting and Financial Reporting - The company prepares financial statements based on actual transactions and events in accordance with the accounting standards issued by the Ministry of Finance[166]. - The financial statements reflect the company's financial position, operating results, changes in shareholders' equity, and cash flows accurately and completely[169]. - The company's accounting period runs from January 1 to December 31 each year[170].